insider image

At Globus Medical, David Paul Chooses To Exercise Options, Resulting In $2.16M

A substantial insider activity was disclosed on December 10, as Paul, Executive Chairman at Globus Medical (NYSE:GMED), reported the exercise of a large sell of company stock options.

What Happened: A Form 4 filing with the U.S. Securities and Exchange Commission on Wednesday revealed that Paul, Executive Chairman at Globus Medical in the Health Care sector, exercised stock options for 34,375 shares of GMED stock. The exercise price of the options was $25.52 per share.

Currently, Globus Medical shares are trading up 0.46%, priced at $88.22 during Thursday's morning. This values Paul's 34,375 shares at $2,155,312.

Discovering Globus Medical: A Closer Look

Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.

Breaking Down Globus Medical's Financial Performance

Revenue Growth: Globus Medical's remarkable performance in 3 months is evident. As of 30 September, 2025, the company achieved an impressive revenue growth rate of 22.91%. This signifies a substantial increase in the company's top-line earnings. As compared to its peers, the company achieved a growth rate higher than the average among peers in Health Care sector.

Analyzing Profitability Metrics:

  • Gross Margin: With a high gross margin of 67.16%, the company demonstrates effective cost control and strong profitability relative to its peers.

  • Earnings per Share (EPS): With an EPS below industry norms, Globus Medical exhibits below-average bottom-line performance with a current EPS of 0.88.

Debt Management: The company maintains a balanced debt approach with a debt-to-equity ratio below industry norms, standing at 0.03.

Market Valuation:

  • Price to Earnings (P/E) Ratio: With a lower-than-average P/E ratio of 28.42, the stock indicates an attractive valuation, potentially presenting a buying opportunity.

  • Price to Sales (P/S) Ratio: The current P/S ratio of 4.37 is below industry norms, suggesting potential undervaluation and presenting an investment opportunity for those considering sales performance.

  • EV/EBITDA Analysis (Enterprise Value to its Earnings Before Interest, Taxes, Depreciation & Amortization): The company's EV/EBITDA ratio 16.18 is below the industry average, indicating that it may be relatively undervalued compared to peers.

Market Capitalization: Indicating a reduced size compared to industry averages, the company's market capitalization poses unique challenges.

Now trade stocks online commission free with Charles Schwab, a trusted and complete investment firm.

Understanding the Significance of Insider Transactions

It's important to note that insider transactions alone should not dictate investment decisions, but they can provide valuable insights.

Considering the legal perspective, an "insider" is defined as any officer, director, or beneficial owner holding more than ten percent of a company's equity securities, according to Section 12 of the Securities Exchange Act of 1934. This includes executives in the c-suite and major hedge funds. These insiders are mandated to disclose their transactions through a Form 4 filing, to be submitted within two business days of the transaction.

Pointing towards optimism, a company insider's new purchase signals their positive anticipation for the stock to rise.

Nevertheless, insider sells may not necessarily indicate a bearish view and can be influenced by various factors.

Navigating the World of Insider Transaction Codes

Digging into the details of stock transactions, investors frequently turn their attention to those taking place in the open market, as outlined in Table I of the Form 4 filing. A P in Box 3 indicates a purchase, while S signifies a sale. Transaction code C signals the conversion of an option, and transaction code A denotes a grant, award, or other acquisition of securities from the company.

Check Out The Full List Of Globus Medical's Insider Trades.

Insider Buying Alert: Profit from C-Suite Moves

Benzinga Edge reveals every insider trade in real-time. Don't miss the next big stock move driven by insider confidence. Unlock this ultimate sentiment indicator now. Click here for access.

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Market News and Data brought to you by Benzinga APIs

Comments
Loading...